Seraxis (Series C)
Funding Details
- Awarder
- Inbox
- Date Award
- February 10, 2021
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $40,000,000
Company Info
- Company Description
- Seraxis is a privately held biotechnology company with operations located in the BioHealth Capital Region, Maryland. Seraxis proprietary transplant ready islets and device were developed in house. Seraxis is advancing its cell therapy/device combination, SR-01 to the clinic.
- Market
- Cell therapy and medical devices
- Location
- Germantown, Maryland, USA
- Coinvestors
- Eli Lilly and Company, Frazier Healthcare Partners, JDRF T1D Fund, Polaris Ventures